Società Entasis Therapeutics Holdings Inc.
Azioni
ETTX
US2936141033
Biotecnologia
Attività
Numero di dipendenti: 51
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/11/19 |
Kyle Dow
IRC | Investor Relations Contact | - | - |
Matthew Ronsheim
PRN | Corporate Officer/Principal | 52 | 01/09/20 |
Anna Diaz Triola
PRN | Corporate Officer/Principal | - | 19/07/21 |
John Mueller
PRN | Corporate Officer/Principal | 64 | 01/05/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01/04/18 |
Director/Board Member | 58 | 01/08/17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01/08/17 |
David Meek
CHM | Chairman | 59 | 24/06/19 |
Marianne Zhen
BRD | Director/Board Member | 55 | 11/07/22 |
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 11/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 47 851 779 | 44 441 302 ( 92,87 %) | 0 | 92,87 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-1,22% | 102 Mrd | |
+2,93% | 96,09 Mrd | |
+2,13% | 22,28 Mrd | |
-14,75% | 21,4 Mrd | |
-8,79% | 18,14 Mrd | |
-39,98% | 17,02 Mrd | |
-13,26% | 16,09 Mrd | |
+8,60% | 13,83 Mrd | |
+36,18% | 11,97 Mrd |